Suzhou Basecare Medical Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Bo Liang
Chief executive officer
CN¥3.0m
Total compensation
| CEO salary percentage | 84.4% |
| CEO tenure | 13.6yrs |
| CEO ownership | n/a |
| Management average tenure | 6.5yrs |
| Board average tenure | 2.9yrs |
Recent management updates
Recent updates
Here's Why Shareholders May Want To Be Cautious With Increasing Suzhou Basecare Medical Corporation Limited's (HKG:2170) CEO Pay Packet
May 30
Suzhou Basecare Medical Corporation Limited's (HKG:2170) Shares Leap 27% Yet They're Still Not Telling The Full Story
May 09Suzhou Basecare Medical Corporation Limited (HKG:2170) Screens Well But There Might Be A Catch
Mar 22Is There An Opportunity With Suzhou Basecare Medical Corporation Limited's (HKG:2170) 47% Undervaluation?
Aug 01Lacklustre Performance Is Driving Suzhou Basecare Medical Corporation Limited's (HKG:2170) 27% Price Drop
May 26Are Investors Undervaluing Suzhou Basecare Medical Corporation Limited (HKG:2170) By 48%?
Jul 20CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | CN¥3m | CN¥3m | -CN¥192m |
| Sep 30 2023 | n/a | n/a | -CN¥176m |
| Jun 30 2023 | n/a | n/a | -CN¥160m |
| Mar 31 2023 | n/a | n/a | -CN¥146m |
| Dec 31 2022 | CN¥3m | CN¥3m | -CN¥132m |
| Sep 30 2022 | n/a | n/a | -CN¥133m |
| Jun 30 2022 | n/a | n/a | -CN¥135m |
| Mar 31 2022 | n/a | n/a | -CN¥139m |
| Dec 31 2021 | CN¥4m | CN¥3m | -CN¥144m |
| Sep 30 2021 | n/a | n/a | -CN¥119m |
| Jun 30 2021 | n/a | n/a | -CN¥106m |
| Mar 31 2021 | n/a | n/a | -CN¥490m |
| Dec 31 2020 | CN¥8m | CN¥1m | -CN¥874m |
| Sep 30 2020 | n/a | n/a | -CN¥1b |
| Jun 30 2020 | n/a | n/a | -CN¥1b |
| Mar 31 2020 | n/a | n/a | -CN¥822m |
| Dec 31 2019 | CN¥732k | CN¥602k | -CN¥528m |
Compensation vs Market: Bo's total compensation ($USD419.80K) is above average for companies of similar size in the Hong Kong market ($USD232.85K).
Compensation vs Earnings: Bo's compensation has increased whilst the company is unprofitable.
CEO
Bo Liang (43 yo)
13.6yrs
Tenure
CN¥3,046,000
Compensation
Dr. Bo Liang serves as Executive Director and General Manager at Suzhou Basecare Medical Corporation Limited since December 14, 2010 and serves as its Chairman of the Board since December 14, 2015. Dr. Lia...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman of the Board & GM | 13.6yrs | CN¥3.05m | no data | |
| CTO & Executive Director | 10.2yrs | CN¥1.40m | no data | |
| Chief Quality Officer & Executive Director | 5.8yrs | CN¥677.00k | no data | |
| CFO & Joint Company Secretary | 1.7yrs | no data | no data | |
| Chief Operating Officer | 7.1yrs | CN¥306.00k | no data | |
| Joint Company Secretary | 1.9yrs | no data | no data |
6.5yrs
Average Tenure
42.5yo
Average Age
Experienced Management: 2170's management team is seasoned and experienced (6.5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman of the Board & GM | 13.6yrs | CN¥3.05m | no data | |
| CTO & Executive Director | 8.1yrs | CN¥1.40m | no data | |
| Chief Quality Officer & Executive Director | 2.3yrs | CN¥677.00k | no data | |
| Independent Non-Executive Director | 3.5yrs | CN¥180.00k | no data | |
| Non-Executive Director | 5.7yrs | no data | no data | |
| Non-Executive Director | 7.8yrs | no data | no data | |
| Supervisor | 3.9yrs | no data | no data | |
| Independent Non-Executive Director | less than a year | CN¥84.00k | no data | |
| Independent Non-executive Director | less than a year | CN¥70.00k | no data | |
| Non-executive Director | less than a year | no data | no data | |
| Chairwoman of the Supervisory Board | less than a year | no data | no data | |
| Supervisor | less than a year | no data | no data |
2.9yrs
Average Tenure
42.5yo
Average Age
Experienced Board: 2170's board of directors are not considered experienced ( 2.9 years average tenure), which suggests a new board.